18102-22-2

Basic information

• Product Name: 1-(Chloromethyl)-2,5-dimethyl-3-nitrobenzene
• Synonyms: 1-(Chloromethyl)-2,5-dimethyl-3-nitrobenzene
• CAS NO: 18102-22-2
• Molecular Formula: C₉H₁₀ClNO₂
• Molecular Weight: 199.6342
• Mol File: 18102-22-2.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-(Chloromethyl)-2,5-dimethyl-3-nitrobenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(Chloromethyl)-2,5-dimethyl-3-nitrobenzene(18102-22-2)
• EPA Substance Registry System: 1-(Chloromethyl)-2,5-dimethyl-3-nitrobenzene(18102-22-2)

Safety Data

• Hazardous Substances Data: 18102-22-2(Hazardous Substances Data)

Usage

General Description

1-(Chloromethyl)-2,5-dimethyl-3-nitrobenzene is a chemical compound consisting of a benzene ring with a nitro group and two methyl groups attached. The chloromethyl group is also attached to the benzene ring. 1-(Chloromethyl)-2,5-dimethyl-3-nitrobenzene is commonly used in the production of pharmaceuticals, pesticides, and dyes. It is considered to be hazardous and should be handled with care due to its potential to cause skin and eye irritation, and harmful effects if inhaled or ingested. Additionally, it is important to note that this compound is a potential environmental hazard, and proper measures should be taken to ensure it is disposed of safely and responsibly.

Upstream product

• 50-00-0 formaldehyd 
• 89-58-7 mononitro-p-xylene 

Downstream Products

• 69022-52-2 dimethyl-2,5 nitro-3 benzaldehyde 
• 69022-56-6 3-acetamido-2,5-dimethylcinnamoyl azide 
• 69022-55-5 3-acetamido-2,5-dimethylcinnamic acid 
• 69022-53-3 trans-2,5-dimethyl-3-nitrocinnamic acid 
• 57411-98-0 2,5-Dimethyl-3-hydrazino-phenylacetonitril 
• 57411-96-8 3-Cyanomethyl-2,5-dimethylanilin 
• 57411-95-7 3-Cyanomethyl-2,5-dimethylnitrobenzol 

Relevant articles and documents

HETEROAROMATIC MODULATORS OF THE RETINOID-RELATED ORPHAN RECEPTOR GAMMA

The present invention relates to a compound according to general formula (I) wherein X represents N or CH; R1 is -CN, (C1-C6)alkyl, (C3-C7)cycloalkyl, (3-7 membered)heterocycloalkyl, (5-6 membered)heteroaryl, (C3-C7)cycloalkyl(C1-C4)alkyl, (3-7 membered)heterocycloalkyl-(C1-C4)alkyl or (5-6 membered)heteroaryl- (C1-C4)alkyl; R2 is halogen, cyano, (C1-C4)alkyl or (C3-C7)cycloalkyl; R3 is halogen, cyano, (C1-C4)alkyl, (C1-C4)haloalkyl or (C3-C7)cycloalkyl; R4 is (C1-C4)alkyl or (C1-C4)haloalkyl; R5 is (C1-C6)alkyl, (C3-C7)cycloalkyl, (C1-C6)alkyl-(C3-C7)cycloalkyl, (C3-C7)cycloalkyl-(C1-C6)alkyl, (3-7 membered)heterocycloalkyl, phenyl, (5-6 membered)heteroaryl or -ORa. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds and to intermediates for preparation of said compounds.

Synthesis of potential antineoplastic agents. XXV. Approaches to the pyridocarbazole system

-